SVB Leerink initiated coverage on Selecta Biosciences with a new price target

6/6/22 7:48:05 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

SVB Leerink initiated coverage of Selecta Biosciences with a rating of Outperform and set a new price target of $7.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$SELB

Date	Price Target	Rating	Analyst
8/18/2023	$1.00	Outperform → Market Perform	SVB Securities
6/14/2022	$6.00 → $5.00	Buy	Needham
6/6/2022	$7.00	Outperform	SVB Leerink
11/1/2021	$6.00 → $7.00	Buy	Needham